Futura Medical PLC (GB:FUM)
LSE:FUM
Holding GB:FUM?
Track your performance easily

Futura Medical (FUM) Income Statement

32 Followers

Futura Medical Income Statement

Last quarter (Q4 2022), Futura Medical's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, Futura Medical's net income was £―. See Futura Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
----£ 31.78K£ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
-£ 6.87M£ 5.87M£ 2.93M£ 11.20M£ 7.27M
Operating Income
-£ -6.87M£ -5.87M£ -2.93M£ -11.16M£ -7.27M
Net Non Operating Interest Income Expense
---£ -924.00£ -22.28K£ 27.58K
Other Income Expense
------
Pretax Income
-£ -6.87M£ -5.87M£ -2.93M£ -11.14M£ -7.24M
Tax Provision
-£ -1.02M£ -908.60K£ -519.09K£ -2.22M£ -1.36M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-£ -5.85M£ -4.96M£ -2.41M£ -8.92M£ -5.88M
Basic EPS
-£ -0.02£ -0.02£ -0.01£ -0.04£ -0.04
Diluted EPS
-£ -0.02£ -0.02£ -0.01£ -0.04£ -0.04
Basic Average Shares
-£ 287.48M£ 271.05M£ 243.72M£ 204.66M£ 131.94M
Diluted Average Shares
-£ 287.48M£ 271.05M£ 243.72M£ 204.66M£ 131.94M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-----£ 114.14K
Total Expenses
-£ 6.87M£ -5.87M£ -2.93M£ -11.20M£ 7.27M
Net Income From Continuing And Discontinued Operation
-£ -5.85M£ -4.96M£ -2.41M£ -8.92M£ -5.88M
Normalized Income
-£ -7.90M£ -6.77M£ -3.45M£ -13.36M£ -5.88M
Interest Expense
------
EBIT
-£ -6.87M£ -5.87M£ -2.93M£ -11.14M£ -7.27M
EBITDA
-£ -6.85M£ -5.87M£ -2.93M£ -11.14M£ -7.25M
Currency in GBP

Futura Medical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis